<DOC>
	<DOCNO>NCT00899756</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample blood patient cancer study laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study look epidermal growth factor receptor mutation blood patient advance non-small cell lung cancer .</brief_summary>
	<brief_title>Epidermal Growth Factor Receptor Mutations Blood Patients With Advanced Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine epidermal growth factor receptor ( EGFR ) mutation exist peripheral blood patient advance non-small cell lung cancer ( NSCLC ) . - Estimate frequency EGFR mutation patient . - Correlate presence EGFR mutation blood EGFR mutation primary metastatic NSCLC tumor block . OUTLINE : Patients undergo blood collection analysis epidermal growth factor receptor mutation DNA sequencing . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm advanced nonsmall cell lung cancer Must available tumor tissue block PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>